Automated prostate lesion detection and PI-RADS assessment with deep learning. The relative contributions of the Genomic Prostate Score and comorbidity profile in predicting outcomes in surgically ...

The clinical outcome of second generation anti-hormonal therapy in patients with metastatic castrate-resistant prostate cancer following CHAARTED regimen. This is an ASCO Meeting Abstract from the ...

A large screening trial showed that using prostate-specific antigen density (PSAD) before MRI prevented overdiagnosis and lowered resource use while preserving the detection of clinically significant ...

PSA density is strongly associated with pathological stage and biochemical-free survival after radical prostatectomy for prostate cancer, researchers conclude. In lower grade prostate cancers (biopsy ...

In the wake of more than a decade of controversy over PSA testing, research is emerging that points to new approaches for the stratification of prostate cancer risk. Two noninvasive tests — an ...

Top urologists debunk prostate cancer myths, explain PSA testing, screening guidelines, risk factors, symptoms, and the ...

A single PSA test at midlife may identify men with a low risk of prostate cancer for up to 20 years, supporting longer screening intervals. Men with a low baseline PSA level at midlife have a low risk ...

are aged 50 and over and have asked your GP for a test Doctors also check your PSA level as you go through prostate cancer treatment. It can help them see how well treatment is working. Prostate ...